Blood pressure, angina pills recalled
Health Canada announced a recall of two high blood pressure and angina medications and an antibiotic because some supplies have been mislabelled.
The prescription drugs are Mylan-Minocycline, a generic version of an antibiotic used to treat various types of infections, and Mylan-Amlodipine, which is used to treat hypertension and chest pain.
“The risk to a patient, who is sensitive or allergic to tetracyclines or minocycline, and is taking Mylan-Minocycline to treat their high blood pressure or angina, but is now using Mylan-Amlodipine due to a labelling error, can be life-threatening,” Health Canada stated in a statement Thursday.
A pharmacist complained to the company that one bottle out of an order of four was labeled as Mylan-Amlodipine 5 mg tablets, but contained 100 Mylan-Minocycline 50 mg capsules.
Mylan Pharmaceuticals stated its quality investigation revealed the labelling error and mix of capsules for tablets.
The company is advising pharmacists and wholesalers to return all quantities of the lot (1037180) to Mylan Pharmaceuticals.
The 250-count bottles that were distributed to wholesalers and pharmacies with the same lot number are not part of this recall, the company said.
Mylan is contacting pharmacists who may have received product from this lot and is advising them to contact patients who had an Amlodipine prescription filled on or after Sept. 13, 2010, the date when this Minocycline lot was released to the Canadian market, to ensure that they did not receive mislabelled product.
Patients should contact their pharmacists or doctors if they have any questions.
Back to accessibility links
source : www.cbc.ca
Related News:
- AsiaInfo-Linkage To Establish European Headquarters In United Kingdom
- Renren.com Launches Two New Developer Products
- Company of Heroes 2 Headed for Early 2013 Release
- Huawei To Build First R&D Center In Taiwan
- China Unicom Gained Net Profit Of CNY1 Billion In Q1 2012
- China Firm ‘Ready To Buy’ Britain’s Weetabix
- China’s 99bill.com Launches New Online Payment Brand
- SmartTrans sells MyLife software to Chinese mobile retailer
- Mindax plunges as rift continues
- Brickworks closes third WA plant
Details :
Submited at Friday, March 18th, 2011 at 9:00 am on Health by jessica
Comment RSS 2.0 - leave a comment - trackback